Commitment To Patient Centricity And Diversity: Key Ingredients To A Successful Trial

By Lisa Muirhead, Nathalie Vives, Zaheda Rahman, Louis Johnson, & Crista Casey

As a technology led global CRO with specialist therapeutic expertise in oncology, cell & gene therapy, and rare disease, Cmed has been taking a patient centric approach to trial design for over 20 years.  This article outlines recent changes in industry requirements and notes some of the important patient centric techniques and strategies we continuously leverage that are gaining visibility across the industry and improving clinical trials for both patients and Sponsors.

What is patient centricity and patient diversity?

Generally, “Patient centricity” in the terms of clinical research means designing a treatment, clinical trial, or other health solution centered around the patient. This approach requires feedback from patients, their loved ones, plus caregivers, as well as making decisions based on that feedback.

Clinical trials rely on volunteers, and age, gender, weight, race, ethnicity, and other factors can trigger different reactions in people taking the same treatment. Ensuring diversity among clinical trial participants allow clinical trials to assess if the treatments are safe and effective for people across different communities.